Gold tier: mechanically validated evidence, with its primary source.
4 evidence items · page 1 / 1
95.6 %95.6% of HIV-infected children aged one to ten years vaccinated with Oral Polio Vaccine (OPV) in Jos, Plateau State, Nigeria had detectable IgG antibodies against poliovirus.
Nigeriapoliomyélitepublished 2019The Pan African medical journalPubMeddocument of 2 observations
4.4 %4.4% of HIV-infected children aged one to ten years vaccinated with Oral Polio Vaccine (OPV) in Jos, Plateau State, Nigeria were not producing detectable amounts of antibodies protective against wild-type poliovirus.
Nigeriapoliomyélitepublished 2019The Pan African medical journalPubMeddocument of 2 observations
97.3 %Children aged 24–119 months in selected Nigerian states had poliovirus seroprevalence of 97.3% against PV1, 93.8% against PV2, and 91.3% against PV3.
Nigeriapoliomyélitepublished 2023The Pan African medical journalPubMeddocument of 2 observations
55.6 %Children aged under 24 months in selected Nigerian states had poliovirus seroprevalence of 86.0% against PV1, 55.6% against PV2, and 77.2% against PV3.
Nigeriapoliomyélitepublished 2023The Pan African medical journalPubMeddocument of 2 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.